RedShiftBio Overview

Contact top employees from RedShiftBio

Summary

RedShiftBio is a private company that has been in the industry for 20 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Julien Bradley. Its headquarters is located at Burlington, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of RedShiftBio varies between 5.0M and 25M. Total funding of the company - $39.9M. To connect with RedShiftBio employee register on SignalHire.

RedShiftBio industries

Biotechnology

Headquarters Location

80 Central Street, Boxborough, MA, 01719 US

RedShiftBio Employees Size

10-50 employees

Specialties

Quantum Cascade Lasers, Molecular Spectroscopy, DSC - Differential Scanning Calorimetry, CD-UV – Circular Dichroism Ultraviolet, HPLC-SEC - High Performance Liquid Chromatography-Size Exclusion Chromatography, UV BCA – Ultraviolet BiCinchoninic Acid assay, Protein Characterization, FT-IR, Biotherapeutics Analysis, Biosimilar, Formulation, Secondary Structure, Biologics, Biophysical Characterization, Aggregation, Stability, Antibodies, Drug Discovery, Process Development, titration, Chromatography, Bioprocessing Analytics, Protein A Affinity Chromatography

SIC Code

3577, 3576, 3575, 3600

DMA Code

Greater Boston

Founded

2005

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Independent Company

Contact RedShiftBio

Organization Website

redshiftbio.com

Social Links

Phone Number

781.345.7300

RedShiftBio Competitors

	Founded	Type	Employees	Revenue	Funding
VUV Analytics, Inc.	2009	Privately Held	100 - 250	5M	$22.9M
Moderna	2010	Public Company	1.0K - 5.0K	7B	$3.6B
Regulus Therapeutics	2007	Public Company	25 - 100	15M	$210.9M
CureVac	2000	Privately Held	500 - 1.0K	21.4M	$1.5B
Standard BioTools	1999	Public Company	500 - 1.0K	148.3M	$429.5M
Protagen AG	1997	Privately Held	25 - 100	< 1M	$0
SCIEX	1970	Public Company	1.0K - 5.0K	100M	$0
Molecular Devices	1983	Public Company	1.0K - 5.0K	190M	$0
Creative Proteomics	2004	-	100 - 250	4.5M	$0
BioTek Instruments	1968	-	10000+	-	$-
Hamilton Company	1953	-	500-1000	-	$-
Arrowhead Pharmaceuticals	2004	-	500-1000	-	$-

RedShiftBio Funding

By Q4 2020, RedShiftBio has participated in at least 7 funding rounds and has raised a minimum of 39.9M. Funding increased noticeable in Q4 2020 — by 6.1M compared to the previous Q2 2020. RedShiftBio raised the least in Q2 2020 at 350.0K, while the most successful funding round in Q1 2020 raised 18.0M.